A Phase I II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan - Chemotherapy - Document - PDFSEARCH.IO

First Page	Meta Content
	A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date Dan Add to Reading List Document Date: 2016-12-05 13:18:26 Open Document File Size: 1,05 MB Share Result on Facebook

A Phase I/II Study of GMI-1271, a Novel E-selectin Antagonist, in Combination with Induction Chemotherapy in Relapsed/Refractory and Previously Untreated Elderly Patients with Acute Myeloid Leukemia; Results to Date DanAdd to Reading List